About
AnchorDx is a pioneer of applying ctDNA methylation sequencing technology in early detection of cancers in China.
Keywords
medical equipment manufacturing
biotech partnerships
medical device certification
services
ctdna
pulmopath ct
wclc conference
genomic platforms
if=15.9
clinical validation
b2b
pulmopath-
clinical epigenetics
medical research publications
fish testing
medical devices
biotech innovation
dna anchormonarch
diagnostic accuracy
ce certification
ngs platforms
ce mark
pulmoseek tm plus
wclc 2021 pulmoseek plus
cancer screening
healthcare equipment & supplies
medical research
pulmoseek plus
angel-ii dna
iso13485
Company Information
-
Employees 7
-
Founded 2015
-
Annual Revenue $20000000
-
Total Funding $68000000
Location
Guangzhou, Guangdong, China
